0000103623-24-000070.txt : 20240814 0000103623-24-000070.hdr.sgml : 20240814 20240814163853 ACCESSION NUMBER: 0000103623-24-000070 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240814 DATE AS OF CHANGE: 20240814 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Viking Therapeutics, Inc. CENTRAL INDEX KEY: 0001607678 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461073877 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-37355 FILM NUMBER: 241208855 BUSINESS ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-704-4660 MAIL ADDRESS: STREET 1: 9920 PACIFIC HEIGHTS BLVD, SUITE 350 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SINGLETON J MATTHEW CENTRAL INDEX KEY: 0001243514 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 286 STANWICH ROAD CITY: GREENWICH STATE: CT ZIP: 06830 144 1 primary_doc.xml 144 0001243514 XXXXXXXX LIVE 0001607678 Viking Therapeutics, Inc. 001-37355 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660 SINGLETON J MATTHEW Director common Oppenheimer & Co Inc

85 Broad Street New York NY 10004

20786 1195735.00 110268210 08/14/2024 NASDAQ common 04/28/2015 NQSO Grant issuer N 20786 08/14/2024 n/a Y 8/14 selling pursuant to Rule 10b5-1 trading plan on file dated May 16 2024 - POA on file 08/14/2024 05/16/2024 J. Matthew Singleton